SDC4 and glioblastoma: Ochieng and collaborators have demonstrated that knockdown of syndecan-4 significantly attenuated the invasive capacity and uptake of labeled exosomes and FNH (fetuin-A and histones) nanoparticles of LN229, a highly aggressive glioblastoma cell line [133].